FIELD: biotechnology.
SUBSTANCE: group of inventions is described, including a recombinant non-pathogenic Marek’s disease virus (hereinafter – rMDVnp) for protection of hens from a virus selected from a group consisting of Newcastle disease virus (hereinafter – NDV), infectious laryngotracheitis virus (hereinafter – ILTV), infectious bursitis virus (hereinafter – IBDV), Marek’s disease virus (hereinafter – MDV), and any combination thereof, an immunogenic composition containing rMDVnp, a vaccine containing the immunogenic composition, and a method for protection of chickens from a virus, including the administration of the vaccine. In one implementation, rMDVnp contains at least three heterologous nucleotide sequences located in an insignificant genome site of rMDVnp.
EFFECT: invention expands the arsenal of means for protection of chickens from a virus selected from a group consisting of NDV, ILTV, IBDV, MDV, and any combination thereof.
16 cl, 5 dwg, 9 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT NON-PATHOGENIC STRUCTURES OF MAREK'S DISEASE VIRUS, ENCODING ANTIGENS OF INFECTIOUS LARYNGOTRACHEITIS VIRUS AND INFECTIOUS BURSITIS VIRUS | 2017 |
|
RU2777400C2 |
RECOMBINANT VECTORS EXPRESSING AVIAN INFLUENZA VIRUS ANTIGENS AND APPLICATIONS THEREOF | 2017 |
|
RU2761869C2 |
RECOMBINANT HVT-VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS AND VACCINES CONTAINING THESE VECTORS | 2017 |
|
RU2752836C2 |
CONSTRUCTS OF RECOMBINANT NONPATHOGENIC MAREK'S DISEASE VIRUS CODING ANTIGENS OF INFECTIOUS LARYNGOTRACHEITIS VIRUS AND NEWCASTLE DISEASE VIRUS | 2012 |
|
RU2624037C2 |
CODON-OPTIMIZED NUCLEIC ACID WHICH ENCODES SMN1 PROTEIN, AND USE THEREOF | 2020 |
|
RU2742837C1 |
ISOLATED MODIFIED VPI CAPSID PROTEIN OF ADENO-ASSOCIATED VIRUS OF SEROTYPE 9 (AAV9), CAPSID AND VECTOR BASED THEREON | 2021 |
|
RU2825667C2 |
ISOLATED MODIFIED VP1 CAPSID PROTEIN OF ADENO-ASSOCIATED VIRUS OF SEROTYPE 5 (AAV5), CAPSID AND VECTOR BASED ON IT | 2019 |
|
RU2751592C2 |
MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNISING AVIAN SPECIES | 2013 |
|
RU2658439C2 |
VACCINE BASED ON AAV5 FOR INDUCTION OF SPECIFIC IMMUNITY TO SARS-CoV-2 VIRUS AND/OR PREVENTION OF CORONAVIRUS INFECTION CAUSED BY SARS-CoV-2 | 2020 |
|
RU2783313C1 |
VACCINE BASED ON AAV5 FOR THE INDUCTION OF SPECIFIC IMMUNITY TO THE SARS-CoV-2 VIRUS AND/OR THE PREVENTION OF CORONAVIRUS INFECTION CAUSED BY SARS-CoV-2 | 2021 |
|
RU2761879C1 |
Authors
Dates
2022-09-20—Published
2018-10-11—Filed